Fangzhou Inc. Recognized as an "Outstanding Enterprise in Digital Intelligence" by Analysys Star

Fangzhou Inc. Recognized as an "Outstanding Enterprise in Digital Intelligence" by Analysys Star

HANGZHOU, China, Dec. 17, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was recognized as an "Outstanding Enterprise in Digital Intelligence" on the "Analysys Star 2024 Annual...

European Wine Ambassadors Elevates European Wines Awareness in Asia with Successful Masterclasses and Study Trips to Spain and Greece in 2024

European Wine Ambassadors Elevates European Wines Awareness in Asia with Successful Masterclasses and Study Trips to Spain and Greece in 2024

HONG KONG, Dec. 16, 2024 /PRNewswire/ -- Following last year's successful series of events in Asia, European Wine Ambassadors has been tasked in 2024 to further build on the reputation and create awareness for three European Wine Regions: the...

Bantex Unveils Brand Refresh and Expansion of Product Line at Jakarta Launch Conference

Bantex Unveils Brand Refresh and Expansion of Product Line at Jakarta Launch Conference

JAKARTA, Indonesia, Dec. 14, 2024 /PRNewswire/ -- Bantex, a leader in high-quality stationery, revealed a major brand refresh and an expansion of its product line at a specially arranged brand launch conference on December 13 in Jakarta. A total of...

Experience Beauty with Digital Human Technology: 'Twinit' Ventures into Global Beauty Tech Market with AI Makeup Solution

Experience Beauty with Digital Human Technology: 'Twinit' Ventures into Global Beauty Tech Market with AI Makeup Solution

- Twinit Unveils 3D Vision-Based AI Skin Analysis, Wins CES 2024 Innovation Award SEOUL, South Korea, Dec. 13, 2024 /PRNewswire/ -- EntreReality, a digital human startup headquartered in South Korea, has launched Twinit AI Makeup to establish its...

Xinhua Silk Road: Conference featuring int'l climate investment, financing sees fruitful results

Xinhua Silk Road: Conference featuring int'l climate investment, financing sees fruitful results

BEIJING, Dec. 13, 2024 /PRNewswire/ -- The 2024 Pearl Bay International Climate Investment and Financing Conference concluded on Monday, had seen fruitful results on promoting green development with the power of finance, calling on all parties to...

Syrebo Unveils Innovative Rehab Robots at MEDICA 2024: A Spectacular Showcase!

Syrebo Unveils Innovative Rehab Robots at MEDICA 2024: A Spectacular Showcase!

SHANGHAI, Dec. 11, 2024 /PRNewswire/ -- On November 11, Syrebo showcased several innovative rehabilitation robot products at MEDICA 2024 in Düsseldorf. Its upper limb rehabilitation robot, BCI rehabilitation robot, and newly launched home...

BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL

BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL

SINGAPORE, Dec. 9, 2024 /PRNewswire/ -- A newly published collaborative study [ 1] in the Journal of Hepatology, featuring HistoIndex – a global leader in stain-free digital pathology solutions for managing fibrotic diseases – alongside Merck &...

ATFX Demonstrates Consistent Strong Performance in Q3 2024 Finance Magnates Data

ATFX Demonstrates Consistent Strong Performance in Q3 2024 Finance Magnates Data

HONG KONG, Dec. 5, 2024 /PRNewswire/ -- ATFX, ranked 5th in the Finance Magnates Q3 2024 report, showcased impressive performance with total trading volumes reaching $733.4 billion on its MT4/MT5 platforms. This substantial figure highlights ATFX's...

The 136th Canton Fair: New Quality Productive Forces Driven by Technological Innovation Empowers China's Trade Upgrading

The 136th Canton Fair: New Quality Productive Forces Driven by Technological Innovation Empowers China's Trade Upgrading

GUANGZHOU, China, Dec. 5, 2024 /PRNewswire/ -- The 136th China Import and Export Fair in Guangzhou has been a beacon of achievement with an intended export turnover reaching USD 24.95 billion. Themed "Serving high-quality development, promoting...

Akeso's Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Combination Therapy for PD-(L)1 Resistant NSCLC Showcased in Oral Presentation at 2024 Asian Conference on Lung Cancer

Akeso's Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Combination Therapy for PD-(L)1 Resistant NSCLC Showcased in Oral Presentation at 2024 Asian Conference on Lung Cancer

HONG KONG, Dec. 4, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the results from a prospective, open-label, single-arm, multi-center phase Ib/II clinical study (AK104-IIT-018) of cadonilimab (PD-1/CTLA-4 bispecific...

  • 1
  • ...
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • menu
    menu